| Characteristic | Gabapentin | Pregabalin | Baclofen | Tiagabine | Valproate / Valproic Acid |
|---|---|---|---|---|---|
| Drug Class | Anticonvulsant / GABA analogue | Anticonvulsant / GABA analogue | Muscle relaxant (GABA<sub>B</sub> agonist) | Anticonvulsant (GABA reuptake inhibitor) | Broad-spectrum anticonvulsant |
| Mechanism of Action | Binds α<sub>2δ</sub> subunit of voltage-gated Ca²⁺ channels → ↓ excitatory neurotransmitter release; does not directly act on GABA receptors | Similar to gabapentin; binds α<sub>2δ</sub> Ca²⁺ subunit → ↓ excitatory transmission | GABA<sub>B</sub> receptor agonist → inhibitory signaling in spinal cord | Inhibits GABA reuptake → ↑ extracellular GABA | Enhances GABA availability; also modulates Na⁺ channels and NMDA receptors |
| GABA Direct Effect? | No | No | Yes (indirect, via GABA<sub>B</sub>) | Yes (prevents reuptake) | Yes (multiple mechanisms) |
| FDA-Approved Uses | Neuropathic pain, partial seizures, postherpetic neuralgia | Neuropathic pain, fibromyalgia, partial-onset seizures, diabetic neuropathy | Spasticity (MS, spinal cord injury) | Adjunct for partial seizures | Epilepsy, bipolar disorder, migraine prophylaxis |
| Common Off-Label Uses | Anxiety, restless legs, hot flashes | Anxiety disorders, insomnia | Alcohol withdrawal, trigeminal neuralgia | Anxiety (rare), neuropathic pain | Neuropathic pain, behavioral disorders |
| Typical Dosing Range (Adults) | 300–3600 mg/day (divided) | 150–600 mg/day (divided) | 5–80 mg/day (divided) | 4–56 mg/day (divided) | 750–3000 mg/day (varies widely) |
| Bioavailability | Decreases with higher doses | ~90% (dose-independent) | High | High | High |
| Time to Peak | ~2–3 hours | ~1 hour | ~1–2 hours | ~0.5–2 hours | ~1–4 hours |
| Elimination | Renal | Renal | Renal | Hepatic | Hepatic |
| Common Side Effects | Dizziness, somnolence, peripheral edema, ataxia | Dizziness, somnolence, weight gain, peripheral edema | Drowsiness, weakness, nausea, dizziness | Somnolence, dizziness, tremor, GI upset | Weight gain, tremor, hair loss, GI upset |
| Serious Risks | Respiratory depression (with opioids), rare hypersensitivity | Respiratory depression (with opioids), misuse potential | Withdrawal spasm if abruptly stopped | Cognitive impairment, confusion | Hepatotoxicity, pancreatitis, teratogenicity |
| Abuse / Dependence Potential | Low but misuse reported | Higher than gabapentin; misuse potential documented | Dependence possible; withdrawal symptoms | Low | Low |
| Dose Adjust in Renal Impairment? | Yes | Yes | Yes | No (but caution) | No (metabolized hepatically) |
| Pregnancy Category / Risk | Limited risk data; generally considered after risk/benefit | Similar to gabapentin; consider caution | Limited data | Limited data | High risk—teratogenic (neural tube defects) |
| Key Drug Interactions | Opioids ↑ sedation & respiratory depression | Opioids ↑ sedation & respiratory depression | CNS depressants ↑ sedation | Other CNS depressants | Many (CYP enzyme interactions) |
| Typical Onset for Pain Relief | Days to weeks | Days to weeks | N/A for pain | N/A for pain | Variable |
Notes / What This Means
Gabapentin vs Pregabalin
- Pregabalin is generally more potent, has more predictable bioavailability, and is sometimes considered easier to dose due to dose-independent absorption.
- Gabapentin’s absorption decreases with higher doses, so it often requires more frequent dosing.
- Misuse risk: Pregabalin has somewhat higher abuse potential than gabapentin, especially when combined with opioids or in individuals with substance use histories.
Baclofen
- Primarily used for spasticity, not as an anticonvulsant or first-line neuropathic pain medication.
- GABA<sub>B</sub> agonism can cause significant sedation.
Tiagabine
- Works by blocking GABA reuptake, thereby increasing synaptic GABA — but it’s mainly an adjunct for seizures, not commonly used for pain.
Valproate / Valproic Acid
- Broad-spectrum anticonvulsant with multiple mechanisms including enhancement of GABA signaling.
- Has significant safety considerations, especially in pregnancy and with liver disease.
Quick Practical Takeaways
✅ For neuropathic pain → Gabapentin or pregabalin are often chosen; choice depends on tolerability, dosing convenience, and cost.
✅ For seizures → Valproate and tiagabine have specific seizure uses; pregabalin/gabapentin are adjuncts.
✅ For spasticity → Baclofen is a mainstay.
✅ Safety first → Renal dosing adjustments matter for gabapentin, pregabalin, and baclofen; hepatic metabolism is crucial for valproate.